News

2017 May 15

Researchers identify a drug that blocks some blood cancers

Ethel Cesarman and colleagues have identified a compound that inhibits the growth of a rare blood cancer found in people with HIV-AIDS as well as multiple myeloma. Read more

2017 May 12

This $25,000 physical has found some ‘serious’ health problems. Others say it has serious problems.

Olivier Elemento, Ph.D., comments on a new kind of intensive health screening. Read more

2017 May 12

Utility of prognostic markers in CLL

Richard R. Furman, M.D., discusses the use of prognostic markers in the treatment of patients with chronic lymphocytic leukemia (CLL). Read more

2017 May 12

Increase in incidence of advanced prostate cancer

Jim C. Hu, M.D., discusses the increase in the incidence of advanced prostate cancer in the United States. Read more

Dr. Harel Weinstein (left) with Ph.D. candidate Milka Doktorova (right). Photo by Travis Curry

2017 May 12

Intercampus collaboration enables graduate student scientists to learn from one another

Inter-campus collaborations have allowed graduate students to break new ground in computational biomedicine. Read more

2017 May 11

Stem cell transplant in ethnic populations

Tsiporah B. Shore, MD, associate director of the Blood and Bone Marrow Transplant Program discusses stem cell transplantation in patients of multi-ethnic populations who have hematologic malignancies. Read more

Evi Giannakakou, PhD (left), and David Nanus, MD

2017 May 10

Next Generation

Evi Giannakakou, Ph.D., mentors tomorrow’s investigators. Read more

2017 May 10

SIRT6's ability to suppress cancer cell growth is explained

Ithaca affiliate Hening Lin, Ph.D., has elucidated the function of the SIRT6 proteins as tumor suppressors. Read more

2017 May 10

Ritchie reflects on research underway in Myeloproliferative Neoplasms

Ellen K. Ritchie, M.D., discusses the landscape of myeloproliferative neoplasms (MPNs). Read more

2017 May 10

Leonard highlights agents, approaches in pipeline for hematologic malignancies

John Leonard, M.D., discusses precision medicine, immunotherapy, CAR-T, and other emerging therapies in hematology. Read more

2017 May 10

Double-hit and double-expressor lymphomas

Sarah Rutherford, M.D., discusses the classification and prevalence of double-hit and double-expressor lymphomas. Read more

2017 May 10

Treating AYA patients with Hodgkin Lymphoma

Lisa Giulino Roth, M.D., discusses treating adolescent and young adult patients with Hodgkin lymphoma. Read more

2017 May 10

Midostaurin approval brings new hope in AML

Gail Roboz, M.D., discusses new and emerging treatments for acute myeloid leukemia (AML). Read more

Igor Tulchinsky, Chris Mason and Olivier Elemento

2017 May 09

Using big data to make big strides in medicine

Christopher Mason, Ph.D., explains how a new initiative funded by WorldQuant founder Igor Tulchinsky will help medical researchers make better predictions. Read more

2017 May 09

Classifying T-cell lymphomas

Jia Ruan, M.D., Ph.D., discusses the classification of T-cell lymphomas. Read more

2017 May 09

Next steps in myeloma include combo regimens and achieving MRD

Ruben Niesvizky, M.D., discusses some of the exciting changes that have occurred in the field of multiple myeloma. Read more

2017 May 09

A 'stronger, more holistic' impact

Olivier Elemento, Ph.D., is featured in an article about Cornell's NYC connections. Read more

2017 May 08

Two Weill winners of Pershing Square Sohn Prize

Juan Cubillos-Ruiz and Yimon Aye were among six scientists selected as prestigious Pershing Square Sohn Prize winners. Read more

2017 May 05

New Method Developed to More Accurately Model Colorectal Cancer

Researchers have long struggled to develop preclinical models of colorectal cancer in which the disease forms in the correct anatomical location. Now Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center... Read more

2017 May 05

Patient preferences with MCL treatment

Peter Martin, M.D., assistant professor of medicine, discusses preferences patients have for treatment of their mantle cell lymphoma (MCL). Read more

News

Researchers identify a drug that blocks some blood cancers

This $25,000 physical has found some ‘serious’ health problems. Others say it has serious problems.

Utility of prognostic markers in CLL

Increase in incidence of advanced prostate cancer

Intercampus collaboration enables graduate student scientists to learn from one another

Stem cell transplant in ethnic populations

Next Generation

SIRT6's ability to suppress cancer cell growth is explained

Ritchie reflects on research underway in Myeloproliferative Neoplasms

Leonard highlights agents, approaches in pipeline for hematologic malignancies

Double-hit and double-expressor lymphomas

Treating AYA patients with Hodgkin Lymphoma

Midostaurin approval brings new hope in AML

Using big data to make big strides in medicine

Classifying T-cell lymphomas

Next steps in myeloma include combo regimens and achieving MRD

A 'stronger, more holistic' impact

Two Weill winners of Pershing Square Sohn Prize

New Method Developed to More Accurately Model Colorectal Cancer

Patient preferences with MCL treatment

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters